Regulus Therapeutics Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jul '25 Jul 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Market Capitalization	3,980	4,082	4,592	1,041	3,907	3,988	Upgrade
Market Cap Growth	26.95%	-11.11%	341.10%	-73.35%	-2.05%	-44.39%	Upgrade
Enterprise Value	4,028	4,128	6,130	3,177	6,228	6,738	Upgrade
Last Close Price	1.95	2.00	2.25	1.79	6.70	6.84	Upgrade
PE Ratio	-	-	1.60	-	-	-	Upgrade
Forward PE	-	7.36	7.36	7.36	26.28	-	Upgrade
PS Ratio	7.19	9.51	8.75	1.41	2.52	5.70	Upgrade
PB Ratio	13.56	14.43	10.41	-0.20	6.52	2.14	Upgrade
P/TBV Ratio	16.47	17.26	12.05	-	-	-	Upgrade
P/FCF Ratio	-	-	1262.70	13.38	30.59	33.99	Upgrade
P/OCF Ratio	-	-	851.09	13.28	29.94	8.28	Upgrade
EV/Sales Ratio	7.27	9.62	11.68	4.29	4.01	9.63	Upgrade
EV/EBITDA Ratio	-	-	-	-	24.00	-	Upgrade
EV/FCF Ratio	-32.29	-	1685.68	40.82	48.77	57.42	Upgrade
Debt / Equity Ratio	0.77	0.84	0.06	-0.45	3.86	1.69	Upgrade
Debt / EBITDA Ratio	-	-	-	-	8.45	-	Upgrade
Debt / FCF Ratio	-	-	6.62	29.61	18.13	26.84	Upgrade
Asset Turnover	0.73	0.53	0.24	0.14	0.19	0.07	Upgrade
Inventory Turnover	10.44	10.50	0.90	1.42	0.91	1.02	Upgrade
Quick Ratio	1.12	1.12	2.39	0.06	0.14	0.20	Upgrade
Current Ratio	1.34	1.30	2.50	0.23	0.54	0.55	Upgrade
Return on Equity (ROE)	-30.27%	-31.23%	-	-	-76.41%	-70.01%	Upgrade
Return on Assets (ROA)	-2.27%	-3.10%	-4.07%	-20.08%	-1.33%	-6.19%	Upgrade
Return on Capital (ROIC)	-3.69%	-5.11%	-	-2341.42%	-2.57%	-9.48%	Upgrade
Earnings Yield	-2.39%	-2.48%	62.38%	-453.82%	-25.03%	-49.16%	Upgrade
FCF Yield	-3.13%	-2.12%	0.08%	7.48%	3.27%	2.94%	Upgrade
Buyback Yield / Dilution	-	1.25%	-250.78%	0.38%	-0.03%	-81.21%	Upgrade
Total Shareholder Return	-	1.25%	-250.78%	0.38%	-0.03%	-81.21%	Upgrade

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.